(Q40385211)
Statements
Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas (English)
David R D'Adamo
Sibyl E Anderson
Karen Albritton
Jennifer Yamada
Elyn Riedel
Kelly Scheu
Gary K Schwartz